(SFD) Smithfield Foods Common - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: (N/A)
SFD EPS (Earnings per Share)
SFD Revenue
SFD: Packaged Meats, Bacon, Sausage, Fresh Pork, Ham, Hot Dogs, Heparin, Grains
Smithfield Foods, Inc. is a leading producer of packaged meats and fresh pork, operating globally with a diverse portfolio of brands and products. The companys Packaged Meats segment is a significant player in the market, offering a wide range of products, including bacon, sausage, and deli meats, under various brand names, such as Smithfield, Eckrich, and Nathans Famous, as well as private labels. This segments products are sold to retail and foodservice customers, contributing to the companys revenue.
The Fresh Pork segment processes live hogs into various primal and sub-primal products, which are sold to retail, foodservice, and industrial customers, as well as exported to countries like China, Mexico, and Japan. The companys Hog Production segment is responsible for raising hogs on company-owned and contract farms in the United States and Mexico, providing a stable supply of raw materials for the Fresh Pork segment. Additionally, the Hog Production segment sells grains to external customers, generating additional revenue.
The companys bioscience operations utilize raw materials from hogs to manufacture heparin products, including an active pharmaceutical ingredient used to mitigate the risk of blood clots. This diversification into the pharmaceutical industry provides a unique revenue stream and highlights the companys ability to leverage its core competencies into adjacent markets.
Analyzing the
Forecasting the stocks performance, we can expect a continued upward trend, driven by the companys diversified product portfolio and global presence. The increasing demand for protein-rich foods, particularly in emerging markets, is likely to benefit Smithfield Foods, Inc. With a stable supply chain and a strong brand presence, the company is well-positioned to capitalize on this trend. Based on the
Additional Sources for SFD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
SFD Stock Overview
Market Cap in USD | 8,346m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception | 2025-01-28 |
SFD Stock Ratings
Growth Rating | 34.9 |
Fundamental | 48.9 |
Dividend Rating | 1.0 |
Rel. Strength | 20.8 |
Analysts | 4.38 of 5 |
Fair Price Momentum | 22.95 USD |
Fair Price DCF | 44.91 USD |
SFD Dividends
Dividend Yield 12m | 2.26% |
Yield on Cost 5y | 2.59% |
Annual Growth 5y | 0.00% |
Payout Consistency | 1.0% |
Payout Ratio | % |
SFD Growth Ratios
Growth Correlation 3m | 92.1% |
Growth Correlation 12m | 57.1% |
Growth Correlation 5y | 57.1% |
CAGR 5y | 22.14% |
CAGR/Max DD 5y | 1.51 |
Sharpe Ratio 12m | 0.76 |
Alpha | 15.61 |
Beta | 0.321 |
Volatility | 18.09% |
Current Volume | 397.6k |
Average Volume 20d | 447.2k |
As of June 16, 2025, the stock is trading at USD 23.56 with a total of 397,625 shares traded.
Over the past week, the price has changed by +2.08%, over one month by +2.68%, over three months by +23.46% and over the past year by +22.14%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Smithfield Foods Common (NASDAQ:SFD) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.87 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SFD is around 22.95 USD . This means that SFD is currently overvalued and has a potential downside of -2.59%.
Smithfield Foods Common has received a consensus analysts rating of 4.38. Therefor, it is recommend to buy SFD.
- Strong Buy: 4
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, SFD Smithfield Foods Common will be worth about 24.8 in June 2026. The stock is currently trading at 23.56. This means that the stock has a potential upside of +5.43%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.8 | 5.4% |